Gynecologic Malignancies


Share

Program Content

Activities

  • RUBY dMMR Post Hoc Analysis
    RUBY Post Hoc Analysis: Survival Outcomes With Dostarlimab Plus Chemotherapy by Type of MMR Deficiency in Patients With Endometrial Cancer
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 25, 2024

    Expires: June 24, 2025

  • PACS
    PACS: Sintilimab Plus Paclitaxel and Cisplatin as Neoadjuvant Treatment for FIGO Stage IB3 and IIA2 Cervical Cancer
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 27, 2024

    Expires: June 26, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from GSK.

GSK